STRIDES PHARMA SCIENCE LIMITED — M&A Activity 2026

Feb 17, 2026

==> picture [145 x 47] intentionally omitted <==

February 17, 2026

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited

Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051

Symbol: STAR

Dear Madam/ Sir,

Sub: Completion of acquisition of Neviton Softech Private Limited

Ref: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)

We are pleased to inform you that Arco Lab Private Limited (“Arco Lab”), a wholly owned subsidiary of the Company, has completed acquisition of Neviton Softech Private Limited (“Neviton”).

Neviton is engaged in providing IT services and engineering solutions to a diverse range of businesses. Its core expertise includes developing machine interfaces through IoT devices and integrating live data feeds into real‑time applications.

Arco Lab had previously acquired a 25% equity stake in Neviton in August 2022, followed by an additional 25% stake in January 2024. Pursuant to the current transaction, Arco Lab has acquired the remaining 50% equity interest, thereby resulting in Neviton becoming a wholly owned subsidiary of Arco Lab with effect from February 16, 2026.

The requisite disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI Master Circular dated January 30, 2026, in relation to this transaction is enclosed herewith.

This is for your information and records.

Thanks & regards,

For Strides Pharma Science Limited,

MANJULA Digitally signed by MANJULA RAMAMURT RAMAMURTHY Date: 2026.02.17 HY 14:59:56 +05'30'

Manjula Ramamurthy Company Secretary & Compliance Officer ICSI Membership No. A30515

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

==> picture [145 x 47] intentionally omitted <==

Disclosure under Regulation 30 of SEBI Listing Regulations read with SEBI Master circular HO/ 49/ 14/ 14(7) 2025-CFD – POD 2/ I/ 3762 /2026 dated January 30, 2026

==> picture [468 x 462] intentionally omitted <==

----- Start of picture text -----

Particulars
a) Name of the target entity, details in brief such as size, turnover etc
Neviton Softech Private Limited (Neviton) is into the business of providing IT Services and
engineering solutions to a wide range of businesses. It has expertise in building machine interfaces
through IoT devices and live feeding data into real-time applications.
Arco Lab Private Limited (Arco Lab), a wholly owned subsidiary of the Company currently holds
50% stake in Neviton. Balance 50% stake was held by Universal Alloy Corporation Design S.R.L
(“UACD"), a Romanian Company.
Effective February 16, 2026, Arco Lab has acquired remaining 50% stake in Neviton from UACD
for a cash consideration of Euro 2 million (~INR 21.77 crores).
Financial summary of Neviton for FY25 is provided below:
 Turnover: INR 27.08 crores.
 Profit After Tax: INR 4.26 crores.
 Net-worth: INR 25.20 crores.
b) Whether the acquisition would fall within related party transaction(s) and whether the
promoter/ promoter group/ group companies have any interest in the entity being acquired?
If yes, nature of interest and details thereof and whether the same is done at “arm’s length”.
From Arco Labs perspective, this will be a transaction with related party as the remaining 50% stake
is being acquired from the other shareholder of Neviton.
However, none of the promoters/ promoter group of Strides Pharma Science Limited have any
interest in the proposed transaction.
c) Industry to which the entity being acquired belongs
Information Technology and Engineering Services.
----- End of picture text -----

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

==> picture [145 x 47] intentionally omitted <==

==> picture [468 x 488] intentionally omitted <==

----- Start of picture text -----

d) Objects and impact of acquisition (including but not limited to, disclosure of reasons for
acquisition of target entity, if its business is outside the main line of business of the listed
entity)
Arco Lab Private Limited (Arco Lab), a wholly owned subsidiary Strides, was established to
provide best-in-class business services in driving business and IT transformation, cost efficiencies
and operational excellence and serve as a Global Life Science Capability Centre. Arcolab also
provides IT Infrastructure services, Enterprise Application Services, Manufacturing IT Services,
New Technologies and Cybersecurity services.
With the investment, Neviton and Arcolab synergize their strengths and enables Arcolab to offer
better knowledge-based and IT services ensuring higher scale, scope and significant cash savings
and enable better internal group wise digitization process. Accordingly, Neviton’s acquisition is
complementary to Arco Lab’s business objectives.
e) Brief details of any governmental or regulatory approvals required for the acquisition
None
f) Indicative time period for completion of the acquisition
Immediate.
g) Consideration - whether cash consideration or share swap or any other form and details of
the same
Cash
h) Cost of acquisition and/ or the price at which the shares are acquired
Euro 2 million (~Rs. 21.77 crores) for acquisition of 5,560 Equity shares of Neviton– constituting
up to 50% of paid-up equity share capital of Neviton.
i) Percentage of shareholding/ control acquired and/ or number of shares acquired
With this acquisition, Neviton shall be wholly owned subsidiary of Arco Lab and step-down
subsidiary of Strides.
----- End of picture text -----

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com

==> picture [145 x 47] intentionally omitted <==

==> picture [468 x 335] intentionally omitted <==

----- Start of picture text -----

j) Brief background about the entity acquired in terms of products/ line of business acquired,
date of incorporation, history of last 3 years turnover, country in which the acquired entity
has presence and any other significant information (in brief)
i. Product line/ business:
Neviton Softech Private Limited (Neviton) is into the business of providing IT Services and
engineering solutions to a wide range of businesses. It has expertise in building machine interfaces
through IoT devices and live feeding data into real-time applications.
ii. Date of Incorporation: February 25, 2010
iii. History of last 3 years turnover:
FY 25: ~INR 27.08 crores
FY 24: ~INR 28.19 crores
FY 23: ~INR 24.48 crores
iv. Country in which the acquired entity has presence.
India and USA.
v. Any other significant information (in brief)
None
----- End of picture text -----

---

Strides Pharma Science Limited

CIN: L24230MH1990PLC057062 Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru - 560 076, India Tel: +91-80-6784 0000 Fax: +91 80 6784 0700 Regd Off: ‘ Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703, India Tel: +91-22-2789 2924/ 3199 corpcomm@strides.com; www.strides.com